Department of Dermatology, Başkent University Faculty of Medicine, Ankara, Turkey.
Department of General Surgery, Başkent University Faculty of Medicine, Ankara, Turkey.
J Am Acad Dermatol. 2010 Jan;62(1):96-101. doi: 10.1016/j.jaad.2009.06.022. Epub 2009 Nov 18.
Renal transplant recipients (RTRs) appear to be more susceptible to the development of oral mucosal disease and lip cancer as a result of graft-preserving immunosuppressive therapy. However, reports regarding these pathologies other than lip cancer are scarce and not studied in a detailed manner in this patient population.
The aim of this study was to determine the prevalence rates and clinical features of lip lesions and oral mucosal lesions (OMLs) in RTRs.
In all, 100 consecutive RTRs (21 female and 79 male) and 79 healthy age- and sex-matched control subjects (23 female and 56 male) were screened for all pathologic and pseudopathologic lip lesions and OMLs, with special interest on precancerous and cancerous lesions. Information about possible associated risk factors such as smoking and alcohol consumption was also obtained. Dermatologic investigation included clinical observation and direct microscopic examination, culture, and histopathological evaluation when indicated.
One or more lip lesions, OMLs, or both were noted in every participant of both groups. Fordyce spots on the lips was the most common lesion in the patient group (73%), followed by diffuse gingival enlargement (39%), fissured tongue (35%), and oral candidiasis (26%). The last 3 disorders were significantly more common in RTRs, whereas the frequency of Fordyce spots in patients and control subjects was similar. No actinic cheilitis, lip cancer, or oral malignancy was observed.
This was a relatively small sample size for evaluating precancerous and cancerous lip lesions and OMLs, as they are less frequently observed than benign lesions.
Some of the benign OMLs (oral candidiasis and diffuse gingival enlargement) are increased in RTRs mainly as a result of the immunosuppressive therapy or drug side effects. Precancerous or cancerous lesions were not observed on the lips or the oral mucosa of our RTRs. This finding is in direct contrast with those of previous studies, yet this can be related to the limited sample size of this study regarding these lesions.
由于保存移植物的免疫抑制治疗,肾移植受者(RTR)似乎更容易发生口腔黏膜疾病和唇癌。然而,除唇癌以外的这些病理学的报告很少,并且在该患者群体中没有详细研究。
本研究旨在确定 RTR 中唇病变和口腔黏膜病变(OML)的患病率和临床特征。
共筛选了 100 例连续的 RTR(21 名女性和 79 名男性)和 79 名年龄和性别匹配的健康对照者(23 名女性和 56 名男性),以筛查所有病理性和假性唇病变和 OML,特别关注癌前病变和癌症病变。还获得了与可能的相关危险因素(如吸烟和饮酒)有关的信息。皮肤科检查包括临床观察和直接显微镜检查、培养和必要时的组织病理学评估。
两组的每个参与者均存在一个或多个唇病变、OML 或两者。唇部的福代斯斑点是患者组最常见的病变(73%),其次是弥漫性牙龈肿大(39%)、裂纹舌(35%)和口腔念珠菌病(26%)。后三种疾病在 RTR 中更为常见,而患者和对照组中福代斯斑点的频率相似。未观察到光化性唇炎、唇癌或口腔恶性肿瘤。
由于良性病变比癌前和癌症病变更为常见,因此评估唇癌前和癌症病变以及 OML 的样本量相对较小。
一些良性 OML(口腔念珠菌病和弥漫性牙龈肿大)在 RTR 中增加,主要是由于免疫抑制治疗或药物的副作用。在我们的 RTR 中,未观察到唇部或口腔黏膜的癌前或癌症病变。这一发现与先前的研究直接相反,但这可能与这些病变的研究样本量有限有关。